The first-ever vaccine created by Univ. of Guelph researchers for gut bacteria common in autistic children may also help control some autism symptoms. The groundbreaking study by Brittany Pequegnat and Guelph chemistry Prof. Mario Monteiro appears in the journal Vaccine. They developed a carbohydrate-based vaccine against the gut bug Clostridium bolteae.
C. bolteae is known to play a role in gastrointestinal disorders, and it often shows up in higher numbers in the GI tracts of autistic children than in those of healthy kids. More than 90 percent of children with autism spectrum disorders suffer from chronic, severe gastrointestinal symptoms.
Read more: http://www.laboratoryequipment.com/news/2013/04/vaccine-may-help-control-autism-symptoms